Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
43,000
Employees43,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
43,000
Employees43,000

LLY Key Statistics

Market cap
701.03B
Market cap701.03B
Price-Earnings ratio
126.44
Price-Earnings ratio126.44
Dividend yield
0.64%
Dividend yield0.64%
Average volume
2.44M
Average volume2.44M
High today
$740.58
High today$740.58
Low today
$729.61
Low today$729.61
Open price
$735.67
Open price$735.67
Volume
2.72M
Volume2.72M
52 Week high
$800.78
52 Week high$800.78
52 Week low
$380.77
52 Week low$380.77

LLY News

Quartz 2h
Wegovy's 1.7 milligram dose is no longer in shortage, FDA says - Quartz

A dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food and Drug Administration (FDA) drug shortage database. Are...

Wegovy's 1.7 milligram dose is no longer in shortage, FDA says - Quartz
Yahoo Finance 2h
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk - Yahoo Finance

Just a few short years after coming to market, the latest GLP-1 drugs are showing versatility in battling diseases related to diabetes and obesity, lifting the...

How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk - Yahoo Finance
CNBC 4h
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum - CNBC

Eli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but shortages are worsening , putting the company's earnings at...

Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum - CNBC

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
20.7%
Sell
6.9%

More LLY News

Seeking Alpha 5h
Eli Lilly Q1 Earnings Preview: Weight loss therapies to drive quarterly growth - Seeking Alpha

Eli Lilly (NYSE:LLY) is scheduled to announce Q1 earnings results on Tuesday, April 30th, before market open. Analysts estimate a profit of $2.49 on revenue of...

Eli Lilly Q1 Earnings Preview: Weight loss therapies to drive quarterly growth - Seeking Alpha
Benzinga 7h
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report Eli Lilly and Company (NYSE:LLY) is set to report first-quarter earnings on Tuesday,...

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report
Yahoo Finance 8h
Here's How Much Stock Eli Lilly Repurchased in 2023 - Yahoo Finance

Eli Lilly (NYSE: LLY), a juggernaut on the stock exchange with a $700 billion-plus market capitalization, has a lot going for it these days that should encourag...

Here's How Much Stock Eli Lilly Repurchased in 2023 - Yahoo Finance
Investor's Business Daily 12h
Dow Jones Futures Rise: Nvidia Leads New Buys; Tesla Runs Past Resistance On Elon Musk Move

Dow Jones futures rose slightly Monday morning, along with S&P 500 futures and Nasdaq futures, after a big week for the Nasdaq and leading stocks. X Apple (AA...

Dow Jones Futures Rise: Nvidia Leads New Buys; Tesla Runs Past Resistance On Elon Musk Move
Yahoo Finance 1d
Eli Lilly Just Announced More Good News: Time to Buy? - Yahoo Finance

The pharmaceutical business is a tricky one. Developing novel therapies costs hundreds of thousands of dollars, sometimes more. Many never make it to the market...

Eli Lilly Just Announced More Good News: Time to Buy? - Yahoo Finance
Yahoo Finance 2d
Forget Nvidia, These Unstoppable Stocks Are Better Buys - Yahoo Finance

Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is that expectations may be too high...

Forget Nvidia, These Unstoppable Stocks Are Better Buys - Yahoo Finance
Benzinga 3d
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'

Loading... Loading... Jim Cramer, the host of CNBC’s “Mad Money,” has outlined the key events that investors should keep an eye on in the upcoming week. What...

Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.